Article
MSH3 rs26279 polymorphism increases cancer risk: a meta-analysis.
International journal of clinical and experimental pathology - 1 Jan 2015
Miao Hui-Kai, Chen Li-Ping, Cai Dong-Ping, Kong Wei-Ju, Xiao Li, Lin Jie
Abstract excerpt
Previous studies have investigated the association of mutS homolog 3 (MSH3) rs26279 G > A polymorphism with the risk of different types of cancers including colorectal cancer, breast cancer, prostate cancer, bladder cancer, thyroid cancer, ovarian cancer and oesophageal cancer. However, its association with cancer remains conflicting. We performed a comprehensive meta-analysis to derive a more precise estimation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
